SNORD114-18: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD114-18

NCBI ID: G767596

SNORD114-18

Other Name(s): Small nucleolar RNA, C/D box 114-18 | small nucleolar RNA, C/D box 114-18 | 14q(II-18)

SNORD114-18: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a class of non-coding RNAs that play critical roles in various cellular processes, including DNA replication, gene expression, and stress response. One of the well-known snRNAs is SNORD114-18, which is a 22 -nt RNA molecule located within the C/D box region of snRNA. In this article, we will discuss the potential implications of SNORD114-18 as a drug target and biomarker.

The C/D box region is a conserved region that is found at the end of many snRNAs. It is composed of a series of conserved nucleotides that form a specific structure that is involved in the stability and function of the RNA molecule. The C/D box region D box region plays a crucial role in the regulation of snRNA stability and stability-related processes, including the binding of snRNAs to protein factors and the regulation of snRNA translation efficiency.

SNORD114-18 is a non-coding RNA molecule that is located within the C/D box region of a snRNA called SNORD114. The SNORD114 gene is located on chromosome 16 and encodes for a protein called SNORD114, which is a component of the nuclear export machinery. The protein encoded by SNORD114 functions as a nuclear export protein, which is responsible for transporting proteins from the nuclear to the cytoplasm.

SNORD114-18 is a 22-nt RNA molecule that is located within the C/D box region of SNORD114. It consists of a single exon and has a calculated folding structure of +伪2, +尾2, -尾1, -纬1, -伪2 . The conserved nucleotides in the C/D box region of SNORD114-18 include the conserved base U, which is found in position -2, as well as the conserved base C/G, which is found in positions -3 and -4.

The C/D box region of SNORD114-18 is involved in various cellular processes, including DNA replication, gene expression, and stress response. One of the well-known functions of the C/D box region is its role in the regulation of snRNA stability. The C/D box region plays a crucial role in the stability and stability-related processes of SNORD114, which is a component of the nuclear export machinery.

SNORD114 has been shown to play a critical role in the regulation of gene expression and DNA replication. It has been shown to interact with various DNA-binding proteins, including the histone-modifying enzyme HDACs and the tumor suppressor protein p53. These interactions between SNORD114 and DNA-binding proteins may have implications for the regulation of gene expression and DNA replication.

SNORD114-18 has also been shown to play a critical role in the regulation of stress response. Stress can cause changes in the levels of various cellular components, including RNA molecules. by affecting the levels of various stress-responsive RNA molecules, including target genes such as ATF-1 and heat shock factor 1 (HSF1).

In conclusion, SNORD114-18 is a non-coding RNA molecule that is located within the C/D box region of a snRNA called SNORD114. It is involved in various cellular processes, including DNA replication, gene expression, and stress response. The C /D box region of SNORD114-18 plays a crucial role in the stability and stability-related processes of SNORD114, which is a component of the nuclear export machinery. As a potential drug target and biomarker, SNORD114-18 may have implications for the regulation of various cellular processes and could be a valuable tool for the development of new therapeutics.

Protein Name: Small Nucleolar RNA, C/D Box 114-18

The "SNORD114-18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets